2023³â Á¦36ȸ ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ ¹× ÃÑȸ : 2023-08-26 |
|
2023³â Á¦36ȸ ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ ¹× ÃÑȸ : 2023-08-26 ±³À°ÁÖÁ¦ : 2023³â Á¦36ȸ ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ Á¤±âÇмú´ëȸ ¹× ÃÑȸ ÁÖÃÖ±â°ü : ´ëÇѺñ´¢±âÁ¾¾çÇÐȸ À̸ÞÀÏ : app@app2010.com ±³À°Á¾·ù : ºñ´¢ÀÇÇаú Âü¼®¿¹»óÀÎ : 150¸í Áö¿ª : ºÎ»ê±¤¿ª½Ã ¼¼ºÎ¼ö°·á : 40,000¿ø ºñ°í
±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 09:10~10:00 Podium Session I: Renal Cell Carcinoma ±Çµ¿µæ(Àü³²ÀÇ´ë) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 10:00~10:20 Novel Epigenetic and Genetic Regulations in Prostate Cancer °ûö(¼¿ïÀÇ´ë) ÈÞ½Ä 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 10:20~10:40 Break () ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 10:40~11:10 Active surveillance: The Johns Hopkins Experience Christian Pavlovich, MD.(Johns Hopkins Hospital) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 11:10~11:30 Definitely Yes! Á¤º´Ã¢(¼º±Õ°üÀÇ´ë) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 11:30~11:50 Not yet! À̵¿Çö(ÀÌÈÀÇ´ë) ±âŸ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 11:50~12:00 BLUE Çмú»ó ½Ã»ó () ½Ä»ç 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 12:00~13:10 Lunch () ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 13:10~13:40 Àӻ󿬱¸¿¡¼ ÁÁÀº ³í¹®À̶õ? - Åë°èÀû°üÁ¡ À±¼ºÃ¶(¿ï»êÀÇ´ë ÀÇÇÐÅë°èÇб³½Ç) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 13:40~14:40 Podium Session II: Urothelial Cance ¼È£°æ(±¹¸³¾Ï¼¾ÅÍ) ÈÞ½Ä 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 14:40~15:00 Break () ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 15:00~15:20 1) Stereotactic body radiotherapy for kidney cancer ±è¿¬ÁÖ(¿ï»êÀÇ´ë) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 15:20~15:40 2) Appropriate use and remaining questions regarding PSMA PET/CT ÇÏÀ±¼®(°æºÏÀÇ´ë) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 15:40~16:00 3) 2023 EAU/AUA bladder cancer update Á¤½Âȯ(¼¿ïÀÇ´ë) ±³À°½Ã°£ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 16:00~17:00 Podium Session III: Prostate Cancer °ûö(¼¿ïÀÇ´ë) ±âŸ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 17:00~17:20 ÃÑȸ () ±âŸ 08¿ù 26ÀÏ ºÎ»ê BEXCO, Á¦2Àü½ÃÀå 3Ãþ 17:20~17:30 Æóȸ»ç ()
|
Tip. ±³À°ÀÏÁ¤Àº ±³À°±â°üÀÇ »çÁ¤¿¡ µû¶ó º¯°æµÉ ¼ö ÀÖÀ¸¹Ç·Î »çÀü¿¡ ¹Ýµå½Ã ±³À°±â°üÀ¸·Î ¹®ÀÇÇÏ¿© È®ÀÎ ¹Ù¶ø´Ï´Ù. |
|